CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
Hassan Ali Maghraby, Abdel Fattah Mohamed Agameya, Manal Shafik Swelam, Nermeen Ahmed El Dabah, Ola Youssef Ahmed
Clin Exp Reprod Med. 2022;49(2):135-141.   Published online May 30, 2022
DOI: https://doi.org/10.5653/cerm.2021.05155

Excel Download

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
Clinical and Experimental Reproductive Medicine. 2022;49(2):135-141   Crossref logo
Link1 Link2 Link3

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
ClinicoEconomics and Outcomes Research. 2013;381   Crossref logo
Link1

Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone
Fertility and Sterility. 2013;99(7):2000-2008.e1   Crossref logo
Link1 Link2

A comparison of the efficacy and safety of combined highly purified human menopausal gonadotropin (HP-hMG) and highly purified urinary follicle stimulating hormone (HP-uFSH) versus HP-hMG alone for ovarian stimulation
Fertility and Sterility. 2015;104(3):e322-e323   Crossref logo
Link1 Link2

Highly purified human menopausal gonadotropin (hMG-HP; Menopur®) versus purified urinary follicle stimulating hormone (Po-FSH; Ovitrop®) for the induction of superovulation in women undergoing assisted reproductive techniques
Fertility and Sterility. 2002;78:S124   Crossref logo
Link1 Link2

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patients
Fertility and Sterility. 2008;89(6):1685-1693   Crossref logo
Link1 Link2

A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model
Fertility and Sterility. 2010;93(5):1464-1476   Crossref logo
Link1 Link2

Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction
Fertility and Sterility. 2003;80(5):1100-1104   Crossref logo
Link1 Link2

Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients
Fertility and Sterility. 1991;56(6):1048-1053   Crossref logo
Link1 Link2

COST COMPARISON OF HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE (RFSH) FOR CONTROLLED OVARIAN STIMULATION IN US HIGH-RESPONDER PATIENTS BASED ON THE MEGASET-HR TRIAL
Fertility and Sterility. 2021;116(3):e267   Crossref logo
Link1 Link2